Potassium citrate and Ceftazidime drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Potassium citrate (potassium citrate) and Ceftazidime (ceftazidime). Common drug interactions include septic shock among females and respiratory failure among males.
The phase IV clinical study analyzes what interactions people have when they take Potassium citrate and Ceftazidime. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.
What is Potassium citrate?
Potassium citrate has active ingredients of potassium citrate. It is often used in kidney stones. eHealthMe is studying from 5,909 Potassium citrate users. Check the latest studies of Potassium citrate.
What is Ceftazidime?
Ceftazidime has active ingredients of ceftazidime. eHealthMe is studying from 10,327 Ceftazidime users. Check the latest studies of Ceftazidime.
15 people who take Potassium citrate and Ceftazidime together, and have interactions are studied.

What are the common drug interactions of Potassium Citrate and Ceftazidime, by gender? *:
female:
- Septic shock (shock due to blood infection)
- Gastritis (inflammation of stomach)
- Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
- Surgery
- Activities of daily living impaired
- Altered state of consciousness (altered state of mind)
- Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
- Attention deficit/hyperactivity disorder
- C-reactive protein increased
- Clavicle fracture
male:
- Respiratory failure (inadequate gas exchange by the respiratory system)
What are the common drug interactions of Potassium Citrate and Ceftazidime, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
- Activities of daily living impaired
- Altered state of consciousness (altered state of mind)
- Anaemia (lack of blood)
- C-reactive protein increased
- Clavicle fracture
- Constipation
- Contusion (a type of hematoma of tissue in which capillaries)
- Disuse syndrome (deterioration of body systems as a result of prescribed or unavoidable inactivity)
- Dry skin
- Fall
30-39:
- Disorientation (disability in which the senses of time, direction, and recognition of people and places)
- Dizziness
- Dyskinesia (abnormality or impairment of voluntary movement)
- Dyspnoea (difficult or laboured respiration)
- Eye disorder
- Fatigue (feeling of tiredness)
- Headache (pain in head)
- Hyperhidrosis (abnormally increased sweating)
- Mania (a state of abnormally elevated or irritable mood)
- Mood swings (an extreme or rapid change in mood)
40-49:
n/a
50-59:
n/a
60+:
- Septic shock (shock due to blood infection)
- Full blood count decreased
- Mouth ulceration (mouth ulcers)
- Pyrexia (fever)
- Tongue ulceration (ulcers on tongue)
- Respiratory failure (inadequate gas exchange by the respiratory system)
- Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
What are the existing conditions these people have? *
- Hypokalemia (low potassium): 6 people, 40.00%
- Anaemia (lack of blood): 6 people, 40.00%
- Type 2 Diabetes: 6 people, 40.00%
- B Precursor Type Acute Leukaemia (lymphoid cancer): 6 people, 40.00%
- Fever: 6 people, 40.00%
- High Blood Pressure: 6 people, 40.00%
- Mouth Ulcers: 5 people, 33.33%
- Electrolyte Imbalance: 5 people, 33.33%
- Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 5 people, 33.33%
- Epstein-Barr Virus Infection: 5 people, 33.33%
* Approximation only. Some reports may have incomplete information.
Do you take Potassium citrate and Ceftazidime?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Potassium citrate (5,909 reports)
- Ceftazidime (10,327 reports)
Browse all drug interactions of Potassium citrate and Ceftazidime:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Potassium citrate:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Ceftazidime:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Potassium citrate and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Ceftazidime and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Chen F, Zhan Z, "Severe drug-induced immune haemolytic anaemia due to ceftazidime", Blood Transfusion, 2014 Jan .
- Chen F, Zhan Z, "Severe drug-induced immune haemolytic anaemia due to ceftazidime", Blood Transfusion, 2014 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on potassium citrate and ceftazidime (the active ingredients of Potassium citrate and Ceftazidime, respectively), and Potassium citrate and Ceftazidime (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Profen cause Pulmonary Haemorrhage? - 4 seconds ago
- Could Profen cause Testicular Disorder? - 5 seconds ago
- Could Prograf cause Blindness Transient? - 7 seconds ago
- Drug interactions of Eupressyl and Atarax - 8 seconds ago
- Could Advil Liqui-Gels cause Candidiasis? - 12 seconds ago
- Acetaminophen And Codeine Phosphate vs. Fentanyl-50, side effect and effectiveness comparison - 12 seconds ago
- Drug interactions of Lovenox and Prohance - 15 seconds ago
- Could Profen cause Hilar Lymphadenopathy? - 15 seconds ago
- Drug interactions of Trental and Glucophage - 19 seconds ago
- Could Farxiga cause Blood Creatine Phosphokinase Increased? - 21 seconds ago